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Protein phosphatase 2A (PP2A) is a serine and threonine protein phosphatase that regulates cell cycle
progression and apoptosis. PP2A is composed of various subunits. Among these subunits, subunit B plays
an important role in the modulation of PP2A function in the brain. This study investigated PP2A subunit B
expression levels after neuronal cell injury. Middle cerebral artery occlusions (MCAO) were surgically
induced in adult male rats to induce focal cerebral ischemic injury, and brain tissues were collected 24 h
after MCAO. A proteomic approach revealed reduction of PP2A subunit B protein spots in MCAO-
operated animals in comparison to sham-operated animals. Western blot analysis confirmed that MCAO
induces reductions in PP2A subunit B levels. Moreover, glutamate exposure induces neuronal cell death
and leads to reductions of PP2A subunit B levels in a hippocampal-derived cell line. This study
demonstrated the decrease of PP2A subunit B in ischemic neuronal cell injury. These results suggest that
the decrease of PP2A subunit B after ischemic brain injury can mediate neuronal cell death.
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Stroke is a major cause of death from cerebral ischemia.
Cerebral ischemia leads to serious neuronal cell damage and
induces disruption of neuronal function. Middle cerebral artery
occlusion (MCAO) is used as a representative animal model
of ischemic brain injury by inducing serious infarct lesions
and neuronal cell damage (Longa et al, 1989; Ferrer and
Planas, 2003; Koh, 2010). A previous study showed that focal
cerebral ischemic injury caused by MCAO leads to up- and
down-regulation of proteins that mediate neuronal cell death
(Koh, 2010).
Phosphorylation and dephosphorylation mechanisms of
signal transduction related proteins are crucial for cell survival
(Siesjö, 1988). Protein phosphatase 2A (PP2A) is an important
serine and threonine phosphatase and a critical enzyme within
various signal transduction pathways, as it regulates essential
cellular activities such as cell cycle progression, cell division,
apoptosis and development (Milward et al, 1999; Zolnierowicz,
2000; Janssens and Goris, 2001; Sontag, 2001). PP2A is a
heterotrimeric phosphatase that is composed of scaffolding/
structural A, regulatory/targeting B, and catalytic C subunits
(Stone et al, 1987). A and C subunits of PP2A are ubiquitously
expressed, while B subunit is highly enriched in the brain
(Strack et al, 1998; Janssens and Goris, 2001). The A and
C subunits contribute to form a core, while the regulatory
B subunit confers to the PP2A holoenzymes and facilitates
various functions of PP2A. PP2A subunit B plays special roles
in the nervous system (Strack et al, 1998), but little information
is available regarding PP2A subunit B expression levels after
ischemic brain injury. In this study, a proteomic approach
revealed decreases of PPA2 proteins in an animal model of
focal cerebral ischemia. We investigated PP2A subunit B
expression levels in focal cerebral ischemic brain injury and
in glutamate-exposed hippocampal neurons.
All animal experiments were followed a protocol approved
by the Committee for Animal Experimentation at the Gyeongsang
National University. Adult male Sprague-Dawley rats (210-
220 g, n=20) were provided from Samtako Animal Breeding
Center (Osan, Korea) and were randomly divided into two
groups, sham-operated group and MCAO-operated group
(n=10 per group). Animals were housed in temperature (25
oC)
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and lighting-controlled (14L:10D) environment, and allowed
free access to food and water.
Focal cerebral ischemic injury was induced by MCAO
operation (Longa et al, 1989). Rats were anesthetized with
sodium pentobarbital (100 mg/kg). A 4/0 nylon suture with
its tip rounded by heating was introduced into the common
carotid artery and advanced into the right internal carotid
artery to the base of the right middle cerebral artery. Animals
were scarified 24 h after MCAO for the investigation in late
stage of apoptosis. The right cerebral cortex was eliminated.
The tissues were homogenized in lysis buffer (8 M urea, 4%
CHAPS, ampholytes, and 40 mM Tris-HCl) and centrifuged
at 16,000 g for 20 min at 4
oC. The total protein concentration
was determined using the Bradford method (Bio-Rad, Hercules,
CA, USA) according to the manufacturer’s protocol.
A proteomic analysis was performed as previously described
method (Koh, 2010). The first dimensional gel electrophoresis
was carried out with the following steps. The IPG strips (IPG,
17 cm, Bio-Rad) were re-hydrated in rehydration buffer [8
M urea, 2% CHAPS, 20 mM dithiothreitol (DTT), 0.5% IPG
buffer, bromophenol blue] at room temperature that contained
lysed proteins for 13 h. The isoelectric focusing (Protean IEF
Cell, Bio-Rad) for pH 4-7 and pH 6-9 was performed as
followed steps: 250 V (15 min), 10,000 V (3 h), and then
10,000 V to 50,000 V. For the second dimension, strips were
equilibrated in 50 mM Tris, 6 M urea, 30% glycerol, 2% sodium
dodesyl sulfate (SDS) and 1% DTT for 10 min. 2D gel
electrophoresis (Protein-II XI, Bio-Rad) was carried out using
gradient gels (7.5-17.5%) at constant 10 mA/gel when the
dye reached end of the gels. The gels were fixed in a solution
(12% acetic acid, 50% methanol). The fixed gels finally stained
with a sliver solution (0.2% silver nitrate, 0.75 mL/L formaldehyde).
The images of stained gels were scanned by Agfar ARCUS
1200
TM (Agfar-Gevaert, Mortsel, BEL). The protein spots were
detected and their intensities were analyzed using PDQuest
software (Bio-Rad). Differentially expressed proteins were
identified in sham-operated and MCAO-operated animals.
The differentially expressed protein spots were cut and
distained. The gel pieces were reacted with reduction solution
(20 mM DTT in 0.1 M NH4HCO3) and in alkylation solution
(55 mM idoacetamide in 0.1 M NH4HCO3) for 10 min. After
dehydration by acetonitrile, the proteins in gel particles were
cleaved with trypsin-containing digestion buffer (Promegea,
Madison, WI, USA). The extract peptides were used for MALDI-
TOF mass spectrometry (Voyager-DE
TM STR biospectrometry
workstation, Applied Biosystem, Forster City, CA, USA). The
spectra for MALDI-TOF were analyzed using MS-Fit and
ProFound program for identification. SWISS-PROT and NCBI
were used as the protein sequence databases.
A mouse hippocampal cell line (HT22) was grown in
Dulbecco’s modified Eagle’s medium (DMEM, without L-
glutamine) with 10% fetal bovine serum (FBS), streptomycin
(100 µg/mL), and penicillin (100 unit/mL) (Gibco BRL,
Gaithersburg, MD, USA). HT22 cells were incubated at 37
oC
in a humidified incubator with 5% CO2 and 95% air. The
cells were seeded on 60-mm culture dishes at 100,000 cells
per dish. After 24 h, cell density was closely monitored to
prevent excessive growth and was maintained 70% or less
confluence as described
 previously (Maher and Davis, 1996;
Koh, 2007). The medium was changed and cells were treated
with 5 mM glutamate (Sigma; St. Louis, MO, USA) for 24 h.
Ethanol was used at a final
 concentration of 0.1% as a vehicle
control. This concentration
 of ethanol had no effect on cell
viability or glutamate toxicity. The cells were collected for
the Western blot analysis.
For the Western blot analysis, protein samples (30 µg) per
lane were loaded to 10% SDS-polyacrylamide gels and
separated by electrophoresis. Proteins were transferred to a
poly-vinylidene fluoride (PVDF) membrane (Millipore, Billerica,
MA, USA). The membranes were blocked with 5% skim milk
and washed in Tris-buffered saline containing 0.1% Tween-
20 (TBST). The blots were incubated with the following
antibodies: anti-PP2A subunit B (diluted 1:1,000, Cell Signaling
Technology, Beverly, MA, USA) and anti-actin antibodies
(diluted 1:1,000, Santa Cruz Biotechnology, Santa Cruz, CA,
USA) as primary antibodies. The membranes were sequentially
reacted with secondary antibody (1:5,000; Pierce, Rockford,
IL, USA). The immunoblots were visualized on X-ray film
using the ECL Western blot analysis system (Amersham
Pharmacia Biotech, Piscataway, NJ, USA). The intensity analysis
was carried out using SigmaGel 1.0 (Jandel Scientific, San
Rafael, CA, USA) and SigmaPlot 4.0 (SPSS Inc., Point Richmond,
CA, USA). All data are expressed as mean±SEM. The results
in each group were compared by one-way analysis of variance
(ANOVA) followed by Student’s t-test.
In a proteomic approach, PP2A subunit B protein spots
were identified as protein spots with more than two-fold
changes in intensity of the cerebral cortices in MCAO-operated
and sham-operated rats (Figure 1). The peptide mass of PP2A
subunit B is 9/56 and the sequence of this protein is 29%.
PP2A subunit B protein levels are decreased in MCAO-
operated animals compared to sham-operated animals.
Western blot analysis clearly showed that MCAO injury induces
decreases in PP2A subunit B levels (Figure 2). The levels of
PP2A subunit B were 1.05±0.06 and 0.64±0.04 in the cerebral
cortices of sham-operated and MCAO-operated animals,
respectively. Glutamate toxicity induces oxidative stress and
leads to neuronal cell death in HT22 cells (Koh, 2007). InThe decreases of PP2A subunit B in brain injury 75
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Figure 3, glutamate exposure is observed to induce reductions
of PP2A subunit B levels in HT22 cells. The levels of PP2A
subunit B were 0.94±0.03 in the vehicle-treated group, and
0.38±0.02 in the glutamate-treated group, respectively (Figure
3).
MCAO is well accepted as a general method to induce
focal cerebral cortex ischemia in experimental animal models
(Longa  et al, 1989; Ferrer and Planas, 2003; Koh, 2010).
Cerebral ischemia by MCAO leads to neuronal cell death
through various signaling pathways (Li et al, 1997; Ferrer and
Planas, 2003). This study demonstrates the down-regulation
of PP2A subunit B protein in an animal model of MCAO-
induced ischemic brain injury.
In this study, a decrease of PP2A subunit B proteins was
observed after MCAO-induced brain injury using a proteomic
approach. Western blot analysis confirmed that ischemic brain
injury significantly decreases PP2A subunit B levels. A previous
study demonstrated that the activity of PP2A is down-regulated
in Alzheimer’s disease and that the disruption of PP2A is
involved in neurodegenerative disease (Gong et al, 2000).
Moreover, decreased PP2A activity in the brain is involved
in intracellular neurofibirillary tangle formation and neuro-
degeneration (Liu and Wang, 2009). PP2A binds and
dephosphorylates the neuronal microtubule-associated
protein tau (Sontag et al, 1996). Tau promotes tubulin
polymerization and stabilizes microtubules, while hyper-
phosphorylated tau induces axonal degeneration in
Alzeheimer’s disease and leads to central nervous system
disorders (Liu and Wang, 2009). A regulatory B subunit confers
cell specificity to the PP2A holoenzyme in the brain and
regulates PP2A activity (Janssens and Goris, 2001). The results
of this study indicate that decrease of PP2A subunit B proteins
during MCAO injury induces the phosphorylation of tau and
leads to neuronal cell death and damage. An in vitro study
indicated that glutamate toxicity induces oxidative stress and
Figure 3. Western blot analysis of protein phosphatase 2A
(PP2A) subunit B in HT22 cells. Glutamate (5 mM) or vehicle
was exposed to HT22 cells for 24 h. Each lane represents an
individual experimental animal. Densitometric analysis of PP2A
levels is represented as intensity of PP2A to intensity of actin.
Data are shown as mean±SEM. *P<0.05 (vs. Vehicle).
Figure 1. Protein phosphatase 2A (PP2A) subunit B protein
spots identified by MALDI-TOF. Arrows indicate the protein
spots. The intensity of spots was measured using PDQuest
software. The ratio of intensity is described as spots intensity of
middle cerebral artery-occluded (MCAO) animal to spots
intensity of sham-operated animal. Data are shown as mean±
SEM. *P<0.05 (vs. Sham).
Figure 2. Western blot analysis of protein phosphatase 2A
(PP2A) subunit B in the cerebral cortex from sham-operated
and middle cerebral artery-occluded (MCAO) animals. Each
lane represents an individual experimental animal. Densitometric
analysis of PP2A levels is represented as intensity of PP2A to
intensity of actin. Data are shown as mean ± SEM. *P<0.05 (vs.
Sham).76 Phil-Ok Koh
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leads to neuronal cell death. Oxidative stress impedes redox
homeostasis and consequently causes cell death. Previous
studies demonstrated that glutamate exposure leads to
ischemic conditions in HT22 cells and results in neuronal
cell death (Maher and Davis, 1996; Koh, 2007). The present
study found that glutamate exposure induces decreases in
PP2A subunit B levels in HT22 cells. A balance between
protein kinase and phosphatase activity is necessary to maintain
normal cellular function, and therefore phosphatases are as
tightly controlled as kinases. The results of this study suggest
that decreased PP2A activity after ischemic brain injury disturbs
the balance of protein kinase and phosphatase activity and
leads to neurodegenerative conditions. Although further
studies are necessary to disclose the role of PP2A subunit
B in brain injury, the results of the present study demonstrate
that decreases of PP2A subunit B levels in MCAO-induced
injury and in glutamate-exposed HT22 cells regulate neuronal
cell death. Thus, these findings suggest that decreases in PP2A
subunit B can lead to neuronal cell death during ischemic
brain injury.
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